Skip to main content

Animations

MJFF Publications

5421 - 5430 of 6509 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2023
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Ending publication bias: A values-based approach to surface null and negative results
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3003368
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Genetic modulation of mitochondrial NAD+ regeneration does not prevent dopaminergic neuron dysfunction caused by mitochondrial complex I impairment
    Journal Name: Frontiers in Cell and Developmental Biology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3389/fcell.2025.1650462
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Use of Amplified Lewy Body Dementia Fibrils and Autoradiography to Characterize Binding of Radioligand Tg-1-90B to Alpha-Synuclein Fibrils in Postmortem Brain Tissue
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3390/cells14181477
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Evidence‐based standardized sample handling protocol for accurate blood‐based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.70752
    Citation Count: 16
  • Summary Details
    OPEN
    Title: APOE ε4 linked effects on clinical features and neuropathology in dementia with Lewy bodies
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.70795
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Five-Year Longitudinal Trajectories of Non-Motor Symptoms in Relation to Baseline Dopaminergic Decline in Parkinson’s Disease
    Journal Name: Brain Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.dscb.2025.100288
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Amygdalar and hippocampal volume loss in limbic-predominant age-related TDP-43 encephalopathy
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaf201
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Tau protein aggregation associated with SARS-CoV-2 main protease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1371/journal.pone.0288138
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Mitochondrial complex I deficiency induces Alzheimer's disease–like signatures that are reversible by targeted therapy
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.70519
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Identifying individuals at-risk of developing Parkinson’s disease using a population-based recruitment strategy: The Healthy Brain Ageing Kassel Study
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-025-01008-w
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.